Published in Gut on June 01, 2003
Sleeve gastrectomy in rats improves postprandial lipid clearance by reducing intestinal triglyceride secretion. Gastroenterology (2011) 1.64
A dynamic, cytoplasmic triacylglycerol pool in enterocytes revealed by ex vivo and in vivo coherent anti-Stokes Raman scattering imaging. J Lipid Res (2009) 1.51
Is there a fatty acid taste? Annu Rev Nutr (2009) 1.41
Accumulating evidence supports a taste component for free fatty acids in humans. Physiol Behav (2011) 1.13
Differences in partitioning of meal fatty acids into blood lipid fractions: a comparison of linoleate, oleate, and palmitate. Am J Physiol Endocrinol Metab (2008) 1.13
Postprandial metabolism of meal triglyceride in humans. Biochim Biophys Acta (2012) 1.09
The proteome of cytosolic lipid droplets isolated from differentiated Caco-2/TC7 enterocytes reveals cell-specific characteristics. Biol Cell (2011) 1.07
A thermal window for yawning in humans: yawning as a brain cooling mechanism. Physiol Behav (2014) 0.99
Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease. Brain Res (2014) 0.94
Increased intestinal lipid absorption caused by Ire1β deficiency contributes to hyperlipidemia and atherosclerosis in apolipoprotein E-deficient mice. Circ Res (2012) 0.91
Brief oral stimulation, but especially oral fat exposure, elevates serum triglycerides in humans. Am J Physiol Gastrointest Liver Physiol (2008) 0.90
Intestinal mucosal triacylglycerol accumulation secondary to decreased lipid secretion in obese and high fat fed mice. Front Physiol (2012) 0.89
Autophagosomes contribute to intracellular lipid distribution in enterocytes. Mol Biol Cell (2013) 0.89
Meal ingestion provokes entry of lipoproteins containing fat from the previous meal: possible metabolic implications. Eur J Nutr (2004) 0.86
Sensing of dietary lipids by enterocytes: a new role for SR-BI/CLA-1. PLoS One (2009) 0.86
Proteomic analysis of lipid droplets from Caco-2/TC7 enterocytes identifies novel modulators of lipid secretion. PLoS One (2013) 0.84
α-Tocopherol bioavailability is lower in adults with metabolic syndrome regardless of dairy fat co-ingestion: a randomized, double-blind, crossover trial. Am J Clin Nutr (2015) 0.83
Lxr-driven enterocyte lipid droplet formation delays transport of ingested lipids. J Lipid Res (2014) 0.83
Intestinal Cgi-58 deficiency reduces postprandial lipid absorption. PLoS One (2014) 0.79
Glucagon-like peptide-2 regulates release of chylomicrons from the intestine. Gastroenterology (2014) 0.78
Postprandial Metabolism of Macronutrients and Cardiometabolic Risk: Recent Developments, Emerging Concepts, and Future Directions. Adv Nutr (2016) 0.78
Metabolic syndrome increases dietary α-tocopherol requirements as assessed using urinary and plasma vitamin E catabolites: a double-blind, crossover clinical trial. Am J Clin Nutr (2017) 0.77
Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men. PLoS One (2016) 0.76
Oral Fat Exposure Pattern and Lipid Loading Effects on the Serum Triacylglycerol Concentration of Humans. Chemosens Percept (2009) 0.76
Intestinal acyl-CoA:diacylglycerol acyltransferase 2 overexpression enhances postprandial triglyceridemic response and exacerbates high fat diet-induced hepatic triacylglycerol storage. Biochim Biophys Acta (2013) 0.76
Mfge8 regulates enterocyte lipid storage by promoting enterocyte triglyceride hydrolase activity. JCI Insight (2016) 0.75
The effect of consuming low- versus high-glycemic index meals after exercise on postprandial blood lipid response following a next-day high-fat meal. Nutr Diabetes (2016) 0.75
Taste hedonics influence the disposition of fat by modulating gastric emptying in rats. PLoS One (2014) 0.75
Getting the label in: practical research strategies for tracing dietary fat. Int J Obes Suppl (2012) 0.75
Role of Intestinal LXRα in Regulating Post-prandial Lipid Excursion and Diet-Induced Hypercholesterolemia and Hepatic Lipid Accumulation. Front Physiol (2017) 0.75
Atherogenesis: a postprandial phenomenon. Circulation (1979) 3.74
DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis. J Biol Chem (2002) 1.90
Recombinant lipoproteins: implications for structure and assembly of native lipoproteins. Annu Rev Biophys Biophys Chem (1986) 1.51
Chylomicron-sized lipid particles are formed in the setting of apolipoprotein B deficiency. J Lipid Res (1998) 1.34
Postprandial lipemia: the origin of an early peak studied by specific dietary fatty acid intake during sequential meals. Am J Clin Nutr (1996) 1.26
Intracellular triacylglycerol lipase: its role in the assembly of hepatic very-low-density lipoprotein (VLDL). Adv Enzyme Regul (1995) 1.22
Formation and transport of chylomicrons by enterocytes to the lymphatics. Am J Physiol (1986) 1.19
Effects of insulin on adipose tissue blood flow in man. J Physiol (2002) 1.05
The assembly of triacylglycerol-rich lipoproteins: an essential role for the microsomal triacylglycerol transfer protein. Br J Nutr (1998) 1.04
Intracellular movement of triacylglycerols in the intestine. J Lipid Res (1998) 1.02
Chylomicron synthesis by intestinal cells in vitro and in vivo. Atherosclerosis (1998) 1.00
Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J Lipid Res (1994) 0.93
Comparison of triacylglycerol synthesis in rat brown and white adipocytes. Effects of hypothyroidism and streptozotocin-diabetes on enzyme activities and metabolic fluxes. Biochem J (1988) 0.93
The effects of eating and of sham feeding upon the absorption of vitamin A palmitate in man. J Clin Invest (1954) 0.92
Role of triglyceride-rich lipoproteins from the liver and intestine in the etiology of postprandial peaks in plasma triglyceride concentration. Metabolism (1989) 0.91
The intestine expresses pancreatic triacylglycerol lipase: regulation by dietary lipid. Am J Physiol Gastrointest Liver Physiol (2001) 0.91
Carbohydrate ingestion, with transient endogenous insulinaemia, produces both sympathetic activation and vasodilatation in normal humans. Clin Sci (Lond) (2002) 0.88
Synthesis and transport of lipoprotein particles by intestinal absorptive cells in man. J Clin Invest (1971) 0.85
Rapid chylomicron appearance following sequential meals: effects of second meal composition. Br J Nutr (1998) 0.85
Increased dietary triacylglycerol markedly enhances the ability of isolated rabbit enterocytes to secrete chylomicrons: an effect related to dietary fatty acid composition. J Lipid Res (1999) 0.85
Properties of phosphatidate phosphohydrolase and diacylglycerol acyltransferase activities in the isolated rat heart. Effect of glucagon, ischaemia and diabetes. Biochem J (1990) 0.84
Modulation of intestinal and liver fatty acid-binding proteins in Caco-2 cells by lipids, hormones and cytokines. J Cell Biochem (2001) 0.83
Effects of n-3 fatty acids on postprandial triacylglycerol and hormone concentrations in normal subjects. Br J Nutr (1992) 0.83
Absorption and distribution of deuterium-labeled trans- and cis-11-octadecenoic acid in human plasma and lipoprotein lipids. Lipids (1986) 0.83
Second meal effect: modified sham feeding does not provoke the release of stored triacylglycerol from a previous high-fat meal. Br J Nutr (2001) 0.82
ApoB-100 secretion by HepG2 cells is regulated by the rate of triglyceride biosynthesis but not by intracellular lipid pools. Arterioscler Thromb Vasc Biol (1996) 0.81
Is the Golgi apparatus the obligatory final step for lipoprotein secretion by intestinal cells? Tissue Cell (1986) 0.80
Rat intestinal lymph osmolarity during glucose and oleic acid absorption. Am J Physiol (1989) 0.80
Quantitation of apolipoprotein B-48 in triacylglycerol-rich lipoproteins by a specific enzyme-linked immunosorbent assay. Biochim Biophys Acta (1996) 0.79
Luminal and plasma glucose concentrations on intestinal fluid absorption and lymph flow. Am J Physiol (1987) 0.79
Endogenous lipase activity in Caco-2 cells. Biochim Biophys Acta (1998) 0.78
Similarities in surface lipids of chylomicrons from glyceryl and alkyl ester feeding: major components. Lipids (1991) 0.78
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol (2005) 10.16
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis (2000) 6.90
Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Respir Environ Exerc Physiol (1983) 6.45
Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut (1989) 4.59
Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet (1996) 4.33
Circulating immune complexes in inflammatory bowel disease. Clin Exp Immunol (1973) 4.32
Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet (1995) 4.12
Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet (1996) 4.09
Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet (1974) 4.06
Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) (2010) 3.86
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut (1988) 3.66
European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut (2006) 3.57
Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin Exp Immunol (1983) 3.21
In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med (2000) 3.04
New IBD genetics: common pathways with other diseases. Gut (2011) 2.95
Loss of autophagy in erythroid cells leads to defective removal of mitochondria and severe anemia in vivo. Proc Natl Acad Sci U S A (2009) 2.95
Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques. Gut (1984) 2.74
T lymphocyte subsets in human intestinal mucosa: the distribution and relationship to MHC-derived antigens. Clin Exp Immunol (1981) 2.68
Heterogeneity of HLA-DR-positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis. J Clin Pathol (1983) 2.49
Glycaemic index methodology. Nutr Res Rev (2005) 2.47
Anatomy of Denonvilliers' fascia and pelvic nerves, impotence, and implications for the colorectal surgeon. Br J Surg (2000) 2.45
Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. Gut (1989) 2.44
Immunohistological characterisation of intraepithelial lymphocytes of the human gastrointestinal tract. Gut (1981) 2.38
Cap polyposis--an unusual cause of diarrhoea. Gut (1993) 2.38
Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation (2008) 2.38
Lymphocyte subpopulations in the human small intestine. The findings in normal mucosa and in the mucosa of patients with adult coeliac disease. Clin Exp Immunol (1983) 2.34
Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. Br Med J (1974) 2.24
Management of early rectal cancer. Br J Surg (2008) 2.13
Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism (1996) 2.11
Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients. Aliment Pharmacol Ther (2014) 2.11
Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease. Gut (1989) 2.06
Immune complexes in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1977) 2.04
Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia (2009) 2.03
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut (2002) 2.00
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. J Crohns Colitis (2008) 1.99
Predicting outcome in severe ulcerative colitis. Gut (1996) 1.99
The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. Scand J Gastroenterol (1979) 1.98
Interleukin 2 receptor expression by macrophages in inflammatory bowel disease. Clin Exp Immunol (1988) 1.95
Immune complexes in acute and chronic liver disease. Clin Exp Immunol (1978) 1.93
Food intolerance and the irritable bowel syndrome. Gut (1989) 1.88
Regulation of protein metabolism by a physiological concentration of insulin in mouse soleus and extensor digitorum longus muscles. Effects of starvation and scald injury. Biochem J (1979) 1.84
The genetics of inflammatory bowel disease. Gut (1997) 1.83
The association of autoimmune disorders with inflammatory bowel disease. Q J Med (1989) 1.80
Genetics of inflammatory bowel disease. Gut (1994) 1.79
Clinical patterns of familial inflammatory bowel disease. Gut (1996) 1.76
Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia (2002) 1.73
Perianal Crohn's disease. Br J Surg (2004) 1.73
Anti-neutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol (1989) 1.69
Crohn's disease and pregnancy. Gut (1984) 1.66
Local excision of rectal tumours by transanal endoscopic microsurgery. Br J Surg (2007) 1.66
The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes. Diabetologia (2004) 1.65
Role of the faecal stream in the maintenance of Crohn's colitis. Gut (1985) 1.63
A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology (2001) 1.60
Stability of plasma glucose during storage. Ann Clin Biochem (1990) 1.59
Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut (1986) 1.58
Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut (1998) 1.58
T lymphocyte subsets in inflammatory bowel disease: peripheral blood. Gut (1983) 1.57
Effect of heparin on polymerase chain reaction. Lancet (1994) 1.55
Olsalazine in active ulcerative colitis. Br Med J (Clin Res Ed) (1985) 1.55
Immune-complex mediated colitis in rabbits. An experimental model. Gut (1978) 1.54
NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther (2003) 1.54
Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut (2000) 1.52
Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology (1997) 1.52
Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer. Br J Surg (2008) 1.50
Susceptibility loci in inflammatory bowel disease. Lancet (1996) 1.49
Assessment of fat malabsorption. J Clin Pathol (1983) 1.49
Apparent deficiency of mucosal vascular collagen type IV associated with angiodysplasia of the colon. J Clin Pathol (1998) 1.49
Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut (1986) 1.49
The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo. Am J Pathol (2001) 1.49
Monocytes in inflammatory bowel disease: phagocytosis and intracellular killing. J Clin Pathol (1980) 1.47
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol (2012) 1.46
Diversion colitis and involution of the defunctioned anorectum. Gut (1993) 1.46
Chronic immune colitis in rabbits. Gut (1979) 1.46
Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut (2003) 1.42
Hormonal control of metabolism in trauma and sepsis. Clin Endocrinol (Oxf) (1986) 1.42
Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine. Aliment Pharmacol Ther (2002) 1.41
Dukes' staging is poorly understood by doctors managing colorectal cancer. Ann R Coll Surg Engl (2002) 1.41
Skeletal muscle triacylglycerol in the rat: methods for sampling and measurement, and studies of biological variability. J Lipid Res (1980) 1.40
Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. Gut (1992) 1.39
Who was Sago? Histopathology (1990) 1.38
Background turbidity changes during the estimation of urinary albumin. Ann Clin Biochem (1990) 1.38
Mucosal characteristics of pelvic ileal pouches. Gut (1991) 1.38
Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia (2003) 1.37
Plasma catecholamines in patients with acute myocardial infarction and in cardiac arrest. Q J Med (1985) 1.37
Cytokine gene expression in HIV-infected intestinal mucosa. AIDS (1994) 1.37
Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg (1992) 1.36
The relationships between plasma substrates and hormones and the severity of injury in 277 recently injured patients. Clin Sci (Lond) (1979) 1.36
T cells in peripheral blood after gluten challenge in coeliac disease. Gut (2005) 1.36
Effects of metformin on glucose uptake by isolated diaphragm from normal and diabetic rats. Biochem Pharmacol (1972) 1.35
C3 metabolism in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1977) 1.34
CDX1 is an important molecular mediator of Barrett's metaplasia. Proc Natl Acad Sci U S A (2005) 1.34
Hair element content in learning disabled children. Science (1977) 1.33
Ten-year experience of strictureplasty for obstructive Crohn's disease. Br J Surg (1989) 1.33
Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Dis Colon Rectum (2004) 1.32
Analysis of the IBD5 locus and potential gene-gene interactions in Crohn's disease. Gut (2003) 1.31